Affinity Asset Advisors, LLC
- SEC CIK
- 0001773195
- 最新申報
- 2026/8/13
2024 年第 3 季持倉
持倉截至 2024/9/30，2024/11/13 申報。只含多頭部位，變化是跟 2024 年第 2 季比股數。
- 持股檔數
- 77
- 較 2024 年第 2 季 −9
- 總值
- $6.45 億
- 較 2024 年第 2 季 +$963.5 萬 (+1.5%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| XENEXenon Pharmaceuticals Inc. | COM | 1,144,021 | $4,504 萬 | 7.0% | +149,794+15.1% | 加碼 | 歷史 |
| APGEApogee Therapeutics, Inc. | COM | 664,198 | $3,901 萬 | 6.1% | −172,085−20.6% | 減碼 | 歷史 |
| NUVLNuvalent, Inc. | COM | 337,500 | $3,453 萬 | 5.4% | +137,500+68.8% | 加碼 | 歷史 |
| ACLXArcellx, Inc. | COMMON STOCK | 400,000 | $3,340 萬 | 5.2% | −60,000−13.0% | 減碼 | 歷史 |
| ALKSAlkermes plc. | SHS | 1,000,000 | $2,799 萬 | 4.3% | +350,000+53.8% | 加碼 | 歷史 |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 1,400,000 | $2,523 萬 | 3.9% | −50,000−3.4% | 減碼 | 歷史 |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 100,000 | $2,122 萬 | 3.3% | −10,000−9.1% | 減碼 | 歷史 |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 400,000 | $2,044 萬 | 3.2% | −115,000−22.3% | 減碼 | 歷史 |
| NRIXNurix Therapeutics, Inc. | COM | 860,399 | $1,933 萬 | 3.0% | −51,601−5.7% | 減碼 | 歷史 |
| VERAVera Therapeutics, Inc. | CL A | 435,000 | $1,923 萬 | 3.0% | +60,000+16.0% | 加碼 | 歷史 |
| VRNAVerona Pharma plc | SPONSORED ADS | 650,000 | $1,870 萬 | 2.9% | −50,000−7.1% | 減碼 | 歷史 |
| AUTLAutolus Therapeutics plc | SPON ADS | 4,500,000 | $1,634 萬 | 2.5% | +200,000+4.7% | 加碼 | 歷史 |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 965,612 | $1,544 萬 | 2.4% | −170,090−15.0% | 減碼 | 歷史 |
| INZYInozyme Pharma, Inc. | COM | 2,822,318 | $1,476 萬 | 2.3% | −33,934−1.2% | 減碼 | 歷史 |
| SYRESpyre Therapeutics, Inc. | COM NEW | 498,420 | $1,466 萬 | 2.3% | −15,000−2.9% | 減碼 | 歷史 |
| Omeros Corp682143AG7 | NOTE 5.250% 2/1 | – | $1,464 萬 | 2.3% | – | – | – |
| KURAKura Oncology, Inc. | COM | 687,785 | $1,344 萬 | 2.1% | +37,785+5.8% | 加碼 | 歷史 |
| Coherus Biosciences Inc19249HAB9 | NOTE 1.500% 4/1 | – | $1,305 萬 | 2.0% | – | – | – |
| ESTAEstablishment Labs Holdings Inc. | COM | 290,447 | $1,257 萬 | 1.9% | +67,040+30.0% | 加碼 | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 525,000 | $1,194 萬 | 1.9% | +375,000+250.0% | 加碼 | 歷史 |
| WVEWave Life Sciences, Inc. | SHS | 1,400,000 | $1,148 萬 | 1.8% | +1,025,000+273.3% | 加碼 | 歷史 |
| Karyopharm Therapeutics Inc.48576UAA4 | NOTE 3.000%10/1 | – | $961.6 萬 | 1.5% | – | – | – |
| ORKAOruka Therapeutics, Inc. | COM | 349,836 | $857.4 萬 | 1.3% | +349,836 | 新進 | 歷史 |
| RZLTRezolute, Inc. | COM NEW | 1,700,000 | $824.5 萬 | 1.3% | −150,000−8.1% | 減碼 | 歷史 |
| MRUSMerus N.V. | COM | 161,741 | $808.1 萬 | 1.3% | +36,741+29.4% | 加碼 | 歷史 |
| ATXSAstria Therapeutics, Inc. | COM | 725,106 | $798.3 萬 | 1.2% | −250,500−25.7% | 減碼 | 歷史 |
| ONCBeOne Medicines Ltd. | ADR | 35,000 | $785.8 萬 | 1.2% | −75,000−68.2% | 減碼 | 歷史 |
| NAMSNewAmsterdam Pharma Co N.V. | ORDINARY SHARES | 472,390 | $784.2 萬 | 1.2% | +49,235+11.6% | 加碼 | 歷史 |
| BBIOBridgeBio Pharma, Inc. | COM | 300,000 | $763.8 萬 | 1.2% | +200,000+200.0% | 加碼 | 歷史 |
| CLYMClimb Bio, Inc. | COM | 1,500,000 | $763.5 萬 | 1.2% | −170,661−10.2% | 減碼 | 歷史 |
| AXSMAxsome Therapeutics, Inc. | COM | 80,000 | $719.0 萬 | 1.1% | 00.0% | 不變 | 歷史 |
| ERASErasca, Inc. | COM | 2,499,431 | $682.3 萬 | 1.1% | 00.0% | 不變 | 歷史 |
| GERNGeron Corp | COM | 1,500,000 | $681.0 萬 | 1.1% | 00.0% | 不變 | 歷史 |
| CATXPerspective Therapeutics, Inc. | COM NEW | 500,000 | $667.5 萬 | 1.0% | −50,000−9.1% | 減碼 | 歷史 |
| IMVTImmunovant, Inc. | COM | 225,000 | $641.5 萬 | 1.0% | −121,088−35.0% | 減碼 | 歷史 |
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 325,000 | $629.5 萬 | 1.0% | +275,000+550.0% | 加碼 | 歷史 |
| PCVXVaxcyte, Inc. | COM | 50,000 | $571.4 萬 | 0.9% | −10,000−16.7% | 減碼 | 歷史 |
| ARVNArvinas, Inc. | COM | 225,000 | $554.2 萬 | 0.9% | +225,000 | 新進 | 歷史 |
| TERNTerns Pharmaceuticals, Inc. | COM | 600,000 | $500.4 萬 | 0.8% | +600,000 | 新進 | 歷史 |
| SWTXSpringWorks Therapeutics, Inc. | COM | 147,500 | $472.6 萬 | 0.7% | +77,501+110.7% | 加碼 | 歷史 |
| CGEMCullinan Therapeutics, Inc. | COM | 263,817 | $441.6 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| Travere Therapeutics, Inc.89422GAA5 | NOTE 2.250% 3/0 | – | $432.0 萬 | 0.7% | – | 新進 | – |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 125,000 | $424.9 萬 | 0.7% | −350,400−73.7% | 減碼 | 歷史 |
| MLYSMineralys Therapeutics, Inc. | COM | 350,000 | $423.9 萬 | 0.7% | +22,041+6.7% | 加碼 | 歷史 |
| INSMINSMED Inc | COM PAR $.01 | 50,000 | $365.0 萬 | 0.6% | −75,000−60.0% | 減碼 | 歷史 |
| FRNMFreenome, Inc. | CL A ORD SHS | 350,000 | $351.1 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| NXTCNextCure, Inc. | COM | 2,302,598 | $315.5 萬 | 0.5% | +614,643+36.4% | 加碼 | 歷史 |
| SVRASavara Inc | COM | 700,000 | $296.8 萬 | 0.5% | −846,850−54.7% | 減碼 | 歷史 |
| NKTXNkarta, Inc. | COM | 650,000 | $293.8 萬 | 0.5% | +450,000+225.0% | 加碼 | 歷史 |
| MIRMMirum Pharmaceuticals, Inc. | COM | 75,000 | $292.5 萬 | 0.5% | −80,000−51.6% | 減碼 | 歷史 |
| IMTXImmatics N.V. | SHS | 250,000 | $285.3 萬 | 0.4% | −50,000−16.7% | 減碼 | 歷史 |
| BBOTBridgeBio Oncology Therapeutics, Inc. | CL A ORD SHS | 250,000 | $261.3 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| CNTXContext Therapeutics Inc. | COM | 1,321,153 | $258.9 萬 | 0.4% | −297,987−18.4% | 減碼 | 歷史 |
| NARIInari Medical, Inc. | Stock | 60,000 | $247.4 萬 | 0.4% | −140,000−70.0% | 減碼 | 歷史 |
| ROIVRoivant Sciences Ltd. | SHS | 201,587 | $232.6 萬 | 0.4% | −150,000−42.7% | 減碼 | 歷史 |
| KZRKezar Life Sciences, Inc. | COM | 2,511,778 | $194.2 萬 | 0.3% | +750,000+42.6% | 加碼 | 歷史 |
| CMPSCOMPASS Pathways plc | SPONSORED ADS | 300,512 | $189.3 萬 | 0.3% | −200,000−40.0% | 減碼 | 歷史 |
| TECXTectonic Therapeutic, Inc. | COM | 58,331 | $176.7 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| NAMSWNewAmsterdam Pharma Co N.V. | *W EXP 11/22/202 | 212,974 | $149.1 萬 | 0.2% | +10,375+5.1% | 加碼 | 歷史 |
| SLNOSoleno Therapeutics Inc | COM | 25,000 | $126.2 萬 | 0.2% | +25,000 | 新進 | 歷史 |
| JBIOJade Biosciences, Inc. | COM | 600,000 | $125.4 萬 | 0.2% | +400,000+200.0% | 加碼 | 歷史 |
| QTTBQ32 Bio Inc. | COM | 27,777 | $123.9 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| VSTMVerastem, Inc. | COM NEW | 400,000 | $119.6 萬 | 0.2% | +400,000 | 新進 | 歷史 |
| BMRNBiomarin Pharmaceutical Inc | COM | 15,000 | $105.4 萬 | 0.2% | +15,000 | 新進 | 歷史 |
| ZURAZura Bio Ltd | CLASS A ORD SHS | 223,335 | $90.7 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| PBYIPuma Biotechnology, Inc. | COM | 250,000 | $63.8 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| RPTXRepare Therapeutics Inc. | COM | 173,351 | $59.6 萬 | 0.1% | +173,351 | 新進 | 歷史 |
| KYTXKyverna Therapeutics, Inc. | COM | 119,900 | $58.6 萬 | 0.1% | −80,100−40.1% | 減碼 | 歷史 |
| ADGMAdagio Medical Holdings, Inc. | COM | 213,235 | $55.0 萬 | 0.1% | +213,235 | 新進 | 歷史 |
| Immatics N.V.N44445117 | *W EXP 07/01/202 | 187,204 | $43.1 萬 | 0.1% | 00.0% | 不變 | – |
| AVTXAvalo Therapeutics, Inc. | COM NEW | 45,000 | $42.6 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| VYGRVoyager Therapeutics, Inc. | COM | 51,727 | $30.3 萬 | <0.1% | +51,727 | 新進 | 歷史 |
| MTVAMetaVia Inc. | COM | 89,222 | $28.3 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| GNLXGENELUX Corp | COM | 100,000 | $23.7 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| WHWKWhitehawk Therapeutics, Inc. | COM | 47,019 | $9.69 萬 | <0.1% | +47,019 | 新進 | 歷史 |
| PMNProMIS Neurosciences Inc. | COM | 30,643 | $3.83 萬 | <0.1% | −235,315−88.5% | 減碼 | 歷史 |
| Rocket Pharmaceuticals, Inc.77313F114 | *W EXP 09/02/202 | 75,000 | $5,250 | <0.1% | 00.0% | 不變 | – |
選擇權（9 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| FLNAFilana Therapeutics, Inc. | COM | $4,265 萬 | – |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | – | $1,802 萬 |
| ANABAnaptysbio, Inc | COM | $670.0 萬 | – |
| SPRYARS Pharmaceuticals, Inc. | COM | – | $580.0 萬 |
| NVAXNovavax Inc | COM NEW | – | $378.9 萬 |
| GALTGalectin Therapeutics Inc | COM NEW | $333.1 萬 | – |
| SMMTSummit Therapeutics Inc. | COM | – | $306.6 萬 |
| SYRSSyros Pharmaceuticals, Inc. | COM NEW | $265.4 萬 | – |
| IMVTImmunovant, Inc. | COM | – | $222.4 萬 |
2024 年第 2 季之後清倉（20 檔）
2024 年第 2 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2024 年第 2 季股數 | 2024 年第 2 季市值 | 2024 年第 2 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| CERECerevel Therapeutics Holdings, Inc. | COM | 500,000 | $2,045 萬 | 3.2% | 歷史 |
| BridgeBio Pharma, Inc.10806XAB8 | NOTE 2.500% 3/1 | – | $1,726 萬 | 2.7% | – |
| Alnylam Pharmaceuticals, Inc.02043QAB3 | NOTE 1.000% 9/1 | – | $1,620 萬 | 2.6% | – |
| MORFMorphic Holding, Inc. | COM | 250,573 | $853.7 萬 | 1.3% | 歷史 |
| ELEVElevation Acquisition Group Inc. | COM | 1,468,825 | $396.6 萬 | 0.6% | 歷史 |
| HLVXHilleVax, Inc. | COM | 265,859 | $384.4 萬 | 0.6% | 歷史 |
| DYNDyne Therapeutics, Inc. | COM | 100,000 | $352.9 萬 | 0.6% | 歷史 |
| State Street SPDR S&P Biotech ETF78464A870 | ETF | 37,550 | $348.1 萬 | 0.5% | – |
| BDTXBlack Diamond Therapeutics, Inc. | COM | 650,000 | $302.9 萬 | 0.5% | 歷史 |
| OLMAOlema Pharmaceuticals, Inc. | COM | 275,000 | $297.6 萬 | 0.5% | 歷史 |
| VIRVir Biotechnology, Inc. | COM | 200,000 | $178.0 萬 | 0.3% | 歷史 |
| ZYMEZymeworks Inc. | COM | 191,127 | $162.6 萬 | 0.3% | 歷史 |
| MRSNMersana Therapeutics, Inc. | COM | 767,000 | $154.2 萬 | 0.2% | 歷史 |
| ARYDARYA Sciences Acquisition Corp IV | CL A | 133,500 | $153.0 萬 | 0.2% | 歷史 |
| ADCTADC Therapeutics SA | SHS | 474,744 | $150.0 萬 | 0.2% | 歷史 |
| TNGXTango Therapeutics, Inc. | COM | 150,274 | $128.9 萬 | 0.2% | 歷史 |
| ORKAOruka Therapeutics, Inc. | COM | 72,484 | $27.8 萬 | <0.1% | 歷史 |
| RAPTRAPT Therapeutics, Inc. | COM | 75,000 | $22.9 萬 | <0.1% | 歷史 |
| PASGPassage BIO, Inc. | COM | 264,266 | $21.0 萬 | <0.1% | 歷史 |
| IOVAIovance Biotherapeutics, Inc. | COM | 100 | $802 | <0.1% | 歷史 |